Jaekyu Shin, PharmD, MS
Professor
Clinical Pharmacy
School of Pharmacy

I provide clinical services at the Pharmacist Care Care Clinic in the Family Health Center at San Francisco General Hospital. This clinic is a referral-based clinic to help resolve various pharmacy issues (e.g., medication reconciliation, adherence, education, access, and dose titration).

Research interests:

I have two main research interests: pharmacy education and cardiovascular therapeutics. In pharmacy education, my research focuses on the generation and implementation of evidence-based practice in pharmacy education including assessment practice. In cardiovascular therapeutics, I am interested in utilizing large databases to conduct pharmacoepidemiology studies for comparative effectiveness/safety studies. In addition, I have been collaborating with other investigators to implement pharmacogenetics testing in clinical practice.

Educational pursuits:

I am Director of Cardiovascular Sciences & Therapeutics, a 1st year pharmacy student course. I also serve as a co-preceptor of Cardiology Advanced Pharmacy Practice Experience (APPE) and Ambulatory Care APPE. I am a co-chair of the Assessment Team in UCSF School of Pharmacy and a member of the Academy of Medical Educators.

• Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
  JAMA internal medicine 2014 Cheng CM, Shin J, Guglielmo BJ
• Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice.
  The American journal of medicine 2013 Shin J, Pletcher MJ
• Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol.
  Pharmacotherapy 2013 Shin J, Gonzales M, Pletcher MJ
• Utilization of cardiac monitoring tests in women with nonmetastatic breast cancer treated with trastuzumab
  Personalized Medicine 2013 Jaekyu Shin, Su-Ying Liang, Michael J. Hassett, Kathryn A. Phillips, Jennifer S. Haas.
• Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation.
  Journal of evaluation in clinical practice 2012 Huang C, Siu M, Vu L, Wong S, Shin J
• Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.
  Pharmacotherapy 2011 Cavallari LH, Shin J, Perera MA
• Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin.
  Pharmacotherapy 2011 Shin J, Pauly DF, Pacanowski MA, Langaee T, Frye RF, Johnson JA
• Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort.
  Pharmacotherapy 2011 Shin J, Kayser SR
• Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort.
  Pharmacogenomics 2011 Shin J, Cao D
• Very important pharmacogene summary ADRB2.
  Pharmacogenetics and genomics 2010 Litonjua AA, Gong L, Duan QL, Shin J, Moore MJ, Weiss ST, Johnson JA, Klein TE, Altman RB
• Survey on warfarin pharmacogenetic testing among anticoagulation providers.
  Pharmacogenomics 2009 Kadafour M, Haugh R, Posin M, Kayser SR, Shin J
• Addressing the challenges of the clinical application of pharmacogenetic testing.
  Clinical pharmacology and therapeutics 2009 Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, UCSF Center for Translational and Policy Research on Personalized Medicine, Walsh JM, Ladabaum U, Marshall D
• Pharmacogenetics: from discovery to patient care.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2009 Shin J, Kayser SR, Langaee TY